CURES and Opioid Pain Management

All dentists who are authorized to prescribe, order, administer, furnish or dispense controlled substances were required to register in the Controlled Substance Utilization Review and Evaluation System (CURES) by July 1, 2016, and must now have updated browsers to access the system. Dispensed controlled substance prescriptions are recorded in CURES, which allows prescribers to look up a patient's controlled substance current usage and past history.

2018 CDA House of Delegates adopts new opioid policy.

Achieve CURES 2.0 compliance. Register now at oag.ca.gov/cures.

CURES CDA Webinar
CDA hosted a webinar presented by the Department of Justice in 2016 to assist members with and answer their questions about the CURES 2.0 registration process.

Resources

CDA continues to promote best practices and compliance with state and federal laws regarding opioid pain management. Utilize this page to access helpful resources below:

CDA Resources
In September 2018, CDA published a special edition of the Update, CDA and Dentistry Working to Reduce Opioid Misuse and Abuse, describing the current environment of opioid misuse and CDA’s leadership on the issue.

CDA Practice Support has published Controlled Substances: Prescribing and Dispensing to help members stay in compliance with all laws and regulations related to controlled-substances prescribing and dispensing, and has developed informed consent forms in English and Spanish.

CDA Presents Courses
CDA has offered courses on the professional, legal and regulatory requirements for pain management and prescribing controlled substances at CDA Presents The Art and Science of Dentistry since September 2015, and continues to offer this course and related courses at its biannual education convention. Learn more about course offerings at CDA Presents.

CDA Journal March 2019 Issue
The March 2019 Journal of the California Dental Association discusses opioid misuse and provides important concepts of substance-abuse disorders, pain management and prescription medication diversion.

CDA Journal November 2015 Issue
The November 2015 Journal of the California Dental Association focuses on the science and practice of pain management in dentistry.

Substance Use Disorder Referral Resources

  • Search and Rescue, an online resource from Partnership for Drug-Free Kids that helps prescribers identify at-risk patients, prescribe responsibly and refer patients to evidence-based treatment.
  • Help for substance use disorders can be found by calling the Substance Abuse and Mental Health Services Helpline at 800.662.HELP (4357)  or on the Substance Abuse and Mental Health Services Administration (SAMHSA) website.

ADA Resources

Dental Board of California

DPA/CCR Statutes and Regulations
To ensure compliance with current California statutes and regulations, always refer to the California Dental Practice Act. Specifically:

Additional Resources

CURES and Opioid News
Legislation, CDA Presents lecture, address prescription opioid abuse and CURES

04/16/2018
On the legislative front, in California alone, more than two dozen bills that address opioid prescription and misuse are working their way through the Legislature, including several by Assemblymember Jim Wood, DDS. Meanwhile, CDA continues to provide education and resources on opioid prescribing to members and dentists throughout California. In May at CDA Presents The Art and Science of Dentistry in Anaheim, CDA Public Affairs will host “Clinical and Legal Considerations for Prescribing Controlled Substances.” Read more >>

 

ADA advances national policy to reduce opioid dependency

03/28/2018
The ADA on March 26 adopted a new policy to combat the opioid epidemic, calling it the potential first of its kind by a major health professional organization to support mandates on opioid prescription limits and continuing education. “I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph P. Crowley, DDS, in a press release. The Interim Board Policy on Opioid Prescribing addresses continuing education, dosage and duration, and prescription and drug monitoring. Read more >>

 

Dentists with DEA numbers must be registered with CURES 2.0

02/21/2018
“All health care practitioners authorized to prescribe or dispense Schedule II-IV controlled substances were required to register to use CURES 2.0 no later than July 1, 2016,” the Dental Board of California reminds dentists in an email distributed late January. California’s Controlled Substance Utilization Review and Evaluation System aids prescribers and dispensers in identifying fraudulent activity and is intended to reduce prescription drug abuse and diversion. Read more >>

 

Resources for dentists as opioid crisis declared public health emergency

11/13/2017
With the U.S. Department of Health and Human Services on Oct. 26 declaring the opioid crisis a public health emergency, CDA reminds dentists, who prescribe approximately 11 percent of prescription opioids annually, of the resources available to them. CDA’s online opioid resource guide at cda.org/opioid is regularly updated with links to resources as they are published. Read more >>

 

CVS Health expands fight against opioid abuse

10/25/2017
CVS Health launched a new initiative in September to help fight the national opioid abuse epidemic by enhancing opioid utilization management, providing drug disposal kiosks nationwide and aiding local communities in treatment and recovery services. The president and CEO of CVS Health said in a news release that addressing the nation’s opioid crisis calls for a multipronged effort involving many health care stakeholders, including dentists. Read more >>

 

Policy statement on opioid abuse adopted by dental board

10/10/2017
In California alone, opioid-related deaths from 2002 to 2014 were up almost 30 percent, and dentists prescribe up to 12 percent of all opioid prescriptions in the U.S. In light of these alarming statistics, the Dental Board of California in August 2017 finalized and adopted a policy statement recognizing the epidemic of opioid abuse in the U.S. Read more >>

 

CURES 'red flags' covered in San Francisco course

07/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. With this in mind, CDA Public Affairs is sponsoring a course to be held at CDA Presents The Art and Science of Dentistry in San Francisco this August that will help dental professionals understand their role in drug diversion programs, including the use of California’s prescription drug monitoring program known as CURES. Read more >>

 

CURES fee exemption available for some dentists

06/22/2017
California prescribers who are registered with the U.S. Drug Enforcement Agency to prescribe, dispense or administer controlled substances must also register to access the state’s prescription drug monitoring program, CURES. A $6 annual ($12 biennial) fee is assessed with licensure renewal in order to maintain the database. Read more >>

 

Course helps dentists respond to opioid abuse epidemic

04/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. A course at CDA Presents in Anaheim will help dental professionals understand the ever-growing problem of prescription drug abuse and dentists' role in drug diversion programs, including the use of California's prescription drug monitoring program known as CURES, Controlled Substance Utilization Review and Evaluation System. Read more >>

 

CDA updates guide to the California Dental Practice Act

03/22/2017
“Your Guide to California Dental Practice Act Compliance” was updated in January 2017 to reflect new laws concerning adverse event reporting, scope of practice, required language in the anesthesia informed consent form, online advertising through Groupon, notice of licensure, prescriber dispensing of controlled substances and several other areas of practice. Read more >>

 

«« First |1 2 3 4 5 | Last ››
Contact
Teresa PichayTeresa Pichay  
Practice Analyst, Regulatory Compliance
916.554.5990

Mary McCuneMary McCune  
Regulatory Analyst/Advocate, Public Affairs
916.554.5359
CURES Regulatory Compliance Alert